TriggerPoint™, the market leader in foam rolling, movement products and education, today announces the launch of the GRID VIBE premium vibrating foam roller. Designed for muscle relaxation and pain reduction, the GRID VIBE pairs TriggerPoint’s patented GRID foam roller design with vibration technology to deliver enhanced muscle mobility experiences.
The GRID VIBE’s vibration frequency is specifically calibrated at 33 hertz for optimal muscle relaxation, minimizing discomfort and allowing users to focus longer on foam rolling tender areas. Research shows that vibration decreases the body’s sensation of pain. When vibration is paired with TriggerPoint’s signature GRID pattern that mimics a massage therapist’s hands, fingers and fingertips, the GRID VIBE effectively targets more layers of tight muscle tissue. The GRID VIBE can be used by anyone for muscle recovery, injury prevention, improving athletic performance, pain management, or boosting overall body movement and mobility.
To view the multimedia release go to:
https://www.multivu.com/players/English/8135751-triggerpoint-grid-vibe-vibrating-foam-roller/
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces today its latest innovation, the Cochlear™ Nucleus® 7 Sound Processor. Approved by the U.S. Food and Drug Administration (FDA) in June, the Nucleus 7 Sound Processor is the world’s first Made for iPhone cochlear implant sound processor and the smallest and lightest behind-the-ear cochlear implant sound processor available on the market.1-3
With the Nucleus 7 Sound Processor, people with a Cochlear Nucleus Implant can now stream sound directly from a compatible iPhone, iPad and iPod touch directly to their sound processor.4,5* They will also be able to control, monitor and customize their hearing on their iPhone or iPod touch through the Nucleus® Smart App available to download for free from the App Store®.
To view the multimedia release go to:
https://www.multivu.com/players/English/7987851-cochlear-nucleus-7-sound-processor/
According to a recent survey, active adults aren’t slowing down. The survey found that 62 percent of adults ages 30-49 continue to work out as much – and with the same or more intensity – as they did in their 20s. More than half would like to ramp up their performance and do more of what they love, but are stopped by pain and the risk of injuries.
Massage Envy’s new, proprietary assisted stretching service, called Total Body Stretch, is designed to help people perform at their best, ease the muscle pain and tension that comes with activity, and resist injuries.
Developed for Massage Envy by an acclaimed chiropractor, massage therapist and ergonomist and performed by a stretching professional, the Total Body Stretch service is built around the company’s proprietary Streto Method, a sequence of 10 targeted stretches designed to increase flexibility, mobility and performance.
To view the multimedia release go to:
https://www.multivu.com/players/English/8133351-massage-envy-streto-total-body-stretch/
Building on a successful campaign that helped hundreds of thousands of Americans learn their risk of developing type 2 diabetes through campaign messaging and an online risk test, the first-of-its-kind initiative to raise national awareness of prediabetes returns with an entertaining new approach. The new campaign, launching today, encourages viewers to take a one-minute prediabetes risk test to know where they stand and discover how they can decrease their risk of developing type 2 diabetes — and it does so with some adorable helpers.
More than one in three American adults has prediabetes — a serious health condition that often leads to type 2 diabetes and other significant health conditions like blindness, heart attack or stroke. According to newly released CDC data, however, nearly 90 percent of the 84 million people with prediabetes don’t know they have it and aren’t aware of the long-term risks to their health. Currently, about 30 million Americans are living with diabetes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8142351-ad-council-prediabetes/
Known as “Paradise On Earth” among the Chinese, Hangzhou has the magic to make travelers forget all their troubles from work and life with its natural scenery, cultural heritage and balanced lifestyle.
In 2016, the G20 Summit brought Hangzhou onto the radar of international travelers; both the New York Times and Travel+Leisure magazine listed it as a top destination last year.
To view the multimedia release go to:
https://www.multivu.com/players/English/8135051-hangzhou-top-asia-travel-destination/
Known as “Paradise On Earth” among the Chinese, Hangzhou has the magic to make travelers forget all their troubles from work and life with its natural scenery, cultural heritage and balanced lifestyle.
In 2016, the G20 Summit brought Hangzhou onto the radar of international travelers; both the New York Times and Travel+Leisure magazine listed it as a top destination last year.
To view the multimedia release go to:
https://www.multivu.com/players/English/8135051-hangzhou-top-asia-travel-destination/
With dozens of possible exterior and interior colour combinations, the choice of the individual is at the centre with the new colourful Volvo XC40, Volvo Cars’ first ever entry in the small premium SUV segment.
The highly anticipated XC40, set to be revealed shortly, will complete Volvo’s SUV line-up with a distinctive car for a distinctive driver.
The XC40 takes Volvo Cars into new areas and allows its designers the freedom to create a car that brings a vibrancy, individuality and playfulness the small premium SUV segment currently lacks.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8141651-individuality-new-volvo-xc40-small-suv/
Texas Instruments (TI) today launched STEM Behind Cool Careers, a series of calculator activities and videos designed to introduce middle and high school students to unexpected science, technology, engineering and math (STEM) careers. The fun, free activities are designed for the TI-Nspire™ CX and TI-84 Plus CE graphing calculators to show students how a solid understanding of STEM subjects is vital for any career, even careers students least expect.
To view the multimedia release go to:
https://www.multivu.com/players/English/7746258-ti-john-urschel-stem-careers/
The Dreaming Tree Wines, a California wine brand from award-winning winemaker Sean McKenzie and musician Dave Matthews, is proud to announce it has hit $1 Million in charitable donations to environmental organizations The Wilderness Society and Living Lands & Waters in support of reforestation and conservation, a goal it set out to achieve six years ago when the brand was launched.
The Dreaming Tree began with a mission to create sustainably produced and packaged wines, as well as ensure that a portion of proceeds from every bottle purchased benefits organizations on the front lines of environmental conservation by planting trees and protecting the nation’s forests. “The more work we can do like this in towns and cities around the world, the more we can change the outcome of the future of those communities,” says The Dreaming Tree Wines co-conspirator Dave Matthews. “I really feel grateful that there are organizations like The Wilderness Society and Living Lands & Waters that can turn this into a reality.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8127651-dreaming-tree-dave-matthews-wine-environmental-conservation-charity-sustainability/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Abila, the leading provider of software and services to nonprofits, associations, and government entities, announced today findings from its Nonprofit Finance Study: Managing Growth. This study explores the trends and challenges associated with nonprofit growth, including how organizations plan to grow in the next few years, growth’s impact on risk management and compliance, and the difficulties maintaining organizational culture during growth.
“Approximately 80 percent of surveyed nonprofits say they plan to grow in the next 12 to 18 months,” said Dan Murphy, senior manager of fund accounting strategy for Abila, and study co-author. “However, oftentimes, with growth comes increased complexity. For example, managing risk, maintaining compliance, and retaining an organization’s unique culture becomes more challenging as organizations adopt a wide variety of growth strategies. Those nonprofits that understand and plan for growth now and in the near future will be primed for success.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7858254-abila-nonprofit-finance-study/
Dornier MedTech® America, a global medical device company and the pioneer of Extracorporeal Shock Wave Lithotripsy (ESWL®), has received FDA clearance to market the Delta® III. This is the latest generation of the world’s best-selling and most clinically cited lithotripter, the Delta II.
To view the multimedia release go to:
https://www.multivu.com/players/English/8134451-dornier-medtech-delta-iii-kidney-stone-lithotripter/
